rs1553248641
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_006147.4(IRF6):c.25C>T(p.Arg9Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R9Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_006147.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF6 | NM_006147.4 | c.25C>T | p.Arg9Trp | missense_variant | 3/9 | ENST00000367021.8 | NP_006138.1 | |
IRF6 | NM_001206696.2 | c.-112+4558C>T | intron_variant | NP_001193625.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRF6 | ENST00000367021.8 | c.25C>T | p.Arg9Trp | missense_variant | 3/9 | 1 | NM_006147.4 | ENSP00000355988.3 | ||
ENSG00000289700 | ENST00000696133.1 | c.25C>T | p.Arg9Trp | missense_variant | 3/10 | ENSP00000512426.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.86e-7 AC: 1AN: 1458682Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 725400
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Van der Woude syndrome;C0265259:Popliteal pterygium syndrome;C1837213:Orofacial cleft 6, susceptibility to Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 11, 2023 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg9 amino acid residue in IRF6. Other variant(s) that disrupt this residue have been observed in individuals with IRF6-related conditions (PMID: 19282774), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IRF6 protein function. ClinVar contains an entry for this variant (Variation ID: 449039). This missense change has been observed in individuals with Van der Woude syndrome (PMID: 15472655, 19449419, 31468312; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 9 of the IRF6 protein (p.Arg9Trp). - |
IRF6-related condition Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 11, 2024 | The IRF6 c.25C>T variant is predicted to result in the amino acid substitution p.Arg9Trp. This variant has been reported in individuals with Van der Woude syndrome (Matsuzawa et al. 2004. PubMed ID: 15472655; Jehee et al. 2009. PubMed ID: 19449419). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 25, 2017 | The R9W variant in the IRF6 gene has previously been reported in association with van der Woude syndrome (Matsuzaka et al., 2004; Jehee et al., 2009). This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R9W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and located within the DNA-binding domain (Little et al., 2009). In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available evidence, R9W is a strong candidate for a pathogenic variant. However, the possibility it may be a rare benign variant cannot be excluded. - |
Van der Woude syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Oct 04, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at